Skip to content

Ardelyx ARDX Interest coverage

Interest coverage at other companies

Amgen logo
AmgenAMGN
3.9×+1.5×
Bausch Health Companies logo
Bausch Health CompaniesBHC
0.4×-0.8×
XER
Xeris Biopharma Holdings, Inc.XERS
1.3×+0.9×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
101×+77.4×
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
29.1×+22.5×
Mineralys Therapeutics, Inc. logo
Mineralys Therapeutics, Inc.MLYS
-8.7×-2.7×

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Calculated from Ardelyx’s reported figures.

Based on trailing twelve months.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's interest coverage.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's interest coverage?
Ardelyx (ARDX) reported interest coverage of -1.7× in Q1 2026.
What is the long-term trend for Ardelyx's interest coverage?
Over 3 years (2020 to 2025), Ardelyx's interest coverage has grown at a -51.5% compound annual growth rate (CAGR), from -17.8× to -2×.
What does interest coverage mean?
Trailing-twelve-month operating income (EBIT) divided by interest expense. Measures how many times over the company can cover its interest payments from operating profit.